Wenn es persönlich wird in der „personalisierten Medizin“: Aufklärung und Kommunikation aus klinischer Forscher- und Patientenperspektive im empirisch-ethischen Vergleich
- 27 July 2013
- journal article
- Published by Springer Science and Business Media LLC in Ethik in der Medizin
- Vol. 25 (3), 215-222
- https://doi.org/10.1007/s00481-013-0263-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- What German experts expect from individualized medicine: problems of uncertainty and future complication in physician–patient interactionClinical Ethics, 2012
- Motivations and Perceptions of Early Adopters of Personalized Genomics: Perspectives from Research ParticipantsPublic Health Genomics, 2011
- Seeking informed consent to Phase I cancer clinical trials: identifying oncologists' communication strategiesPsycho‐Oncology, 2011
- Disentangling cancer patients' trust in their oncologist: a qualitative studyPsycho‐Oncology, 2011
- What Oncologists Believe They Said and What Patients Believe They Heard: An Analysis of Phase I Trial DiscussionsJournal of Clinical Oncology, 2011
- Contribution of biomarkers to personalized medicineBreast Cancer Research, 2010
- Trust, Distrust and Co-production: The Relationship Between Research Biobanks and DonorsPublished by Springer Science and Business Media LLC ,2009
- Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative ChemoradiotherapyJournal of Clinical Oncology, 2005
- Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trialsSocial Science & Medicine (1982), 2003
- Communication styles in the cancer consultation: preferences for a patient-centred approachPsycho‐Oncology, 2000